Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001237503 | SCV001410266 | uncertain significance | Zellweger spectrum disorders | 2022-02-10 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 20 of the PEX1 gene. It does not directly change the encoded amino acid sequence of the PEX1 protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs763767937, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with PEX1-related conditions. ClinVar contains an entry for this variant (Variation ID: 963473). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
3billion, |
RCV004727025 | SCV005328698 | likely benign | Peroxisome biogenesis disorder 1A (Zellweger); Heimler syndrome 1; Peroxisome biogenesis disorder 1B | 2024-09-20 | criteria provided, single submitter | clinical testing | The homozygous variant was found in patients diagnosed with another variant in a different gene, with no symptoms related to the gene containing the homozygous variant. |
Natera, |
RCV001237503 | SCV002076819 | uncertain significance | Zellweger spectrum disorders | 2018-09-03 | no assertion criteria provided | clinical testing |